Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Robert I. Haddad(Dana-Farber Cancer Institute), Anne O’Neill(Dana-Farber Cancer Institute), Guilherme Rabinowits(Dana-Farber Cancer Institute), Roy B. Tishler(Dana-Farber Cancer Institute), Fadlo R. Khuri(Emory University), Douglas R. Adkins(Washington University in St. Louis), Joseph I. Clark(Loyola University Chicago), Nicholas J. Sarlis(Sanofi (United States)), Jochen H. Lorch(Dana-Farber Cancer Institute), Jonathan J. Beitler(Emory University), Sewanti Limaye(Dana-Farber Cancer Institute), Sarah Riley(Dana-Farber Cancer Institute), Marshall R. Posner(Icahn School of Medicine at Mount Sinai)
Cited by 744
Abstract
Related Papers
No related papers found
Powered by citation graph analysis